DIAGNOS Inc.
DGNOF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -39% | -61.2% | 64.3% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | -$1 | -$1 | -$0 | -$0 |
| % Margin | -909% | -492.4% | -95.3% | -130.1% |
| R&D Expenses | $0 | $0 | $1 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $3 | $2 | $2 | $2 |
| Operating Income | -$4 | -$3 | -$3 | -$2 |
| % Margin | -3,671.7% | -1,522.5% | -582.1% | -756% |
| Other Income/Exp. Net | -$0 | -$1 | -$0 | $1 |
| Pre-Tax Income | -$4 | -$3 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$3 | -$3 | -$2 |
| % Margin | -4,129.6% | -1,833.9% | -594.4% | -768.1% |
| EPS | -0.049 | -0.043 | -0.038 | -0.03 |
| % Growth | -13.3% | -14.4% | -25.8% | – |
| EPS Diluted | -0.049 | -0.043 | -0.038 | -0.03 |
| Weighted Avg Shares Out | 88 | 73 | 70 | 69 |
| Weighted Avg Shares Out Dil | 88 | 73 | 70 | 69 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$2 | -$2 | -$2 |
| % Margin | -3,433.7% | -1,437.6% | -478.7% | -916.8% |